Pubblicazioni

The non-functional ACE2 isoform, but not the SARS-CoV-2 receptor, is induced as an interferon-stimulated gene, in SARS-CoV-2 infected adults

2022 - CYTOKINE
Oliveto, Giuseppe; Scagnolari, Carolina; Frasca, Federica; Sorrentino, Leonardo; Matera, Luigi; Nenna, Raffaella; Viscido, Agnese; Scordio, Mirko; Petrarca, Laura; Maria Zicari, Anna; Gentilini, Elio; D'Ettorre, Gabriella; Ceccarelli, Giancarlo; Midulla, Fabio; Antonelli, Guido; Pierangeli, Alessandra

Real-life data on monoclonal antibodies and antiviral drugs in Italian inborn errors of immunity patients during COVID-19 pandemic

2022 - FRONTIERS IN IMMUNOLOGY
Garzi, Giulia; Cinetto, Francesco; Firinu, Davide; Di Napoli, Giulia; Lagnese, Gianluca; Punziano, Alessandra; Bez, Patrick; Cinicola, Bianca Laura; Costanzo, Giulia; Scarpa, Riccardo; Pulvirenti, Federica; Rattazzi, Marcello; Spadaro, Giuseppe; Quinti, Isabella; Milito, Cinzia

Response to 'Is there a future for hydroxychloroquine/chloroquine in prevention of SARS-CoV-2 infection (COVID-19)?' by Moiseev et al

2021 - ANNALS OF THE RHEUMATIC DISEASES
Spinelli, F. R.; Ceccarelli, F.; Di Franco, M.; Conti, F.

SAveRUNNER: A network-based algorithm for drug repurposing and its application to COVID-19

2021 - PLOS COMPUTATIONAL BIOLOGY
Fiscon, G.; Conte, F.; Farina, L.; Paci, P.

SAveRUNNER: an R-based tool for drug repurposing

2021 - BMC BIOINFORMATICS
Fiscon, G.; Paci, P.

Characterization of the trans-epithelial transport of green tea (C. sinensis) catechin extracts with in vitro inhibitory effect against the sars-cov-2 papain-like protease activity

2021 - MOLECULES
Montone, C. M.; Aita, S. E.; Arnoldi, A.; Capriotti, A. L.; Cavaliere, C.; Cerrato, A.; Lammi, C.; Piovesana, S.; Ranaldi, G.; Lagana, A.

Is teicoplanin a complementary treatment option for COVID-19? The question remains

2020 - INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
Ceccarelli, G.; Alessandri, F.; d'Ettorre, G.; Borrazzo, C.; Spagnolello, O.; Oliva, A.; Ruberto, F.; Mastroianni, C. M.; Pugliese, F.; Venditti, M.

Is teicoplanin a complementary treatment option for COVID-19? The question remains

2020 - INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
Ceccarelli, G.; Alessandri, F.; d'Ettorre, G.; Borrazzo, C.; Spagnolello, O.; Oliva, A.; Ruberto, F.; Mastroianni, C. M.; Pugliese, F.; Venditti, M.

Interferon-β-1a inhibition of severe acute respiratory syndrome-coronavirus 2 in vitro when administered after virus infection

2020 - THE JOURNAL OF INFECTIOUS DISEASES
Clementi, N.; Ferrarese, R.; Criscuolo, E.; Diotti, R. A.; Castelli, M.; Scagnolari, C.; Burioni, R.; Antonelli, G.; Clementi, M.; Mancini, N.

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma